[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1116341A1 - Use of polymer mixtures for the production of coated pharmaceutical formulations and pharmaceutical formulation with mixed polymeric coating - Google Patents

Use of polymer mixtures for the production of coated pharmaceutical formulations and pharmaceutical formulation with mixed polymeric coating

Info

Publication number
HK1116341A1
HK1116341A1 HK08106684.0A HK08106684A HK1116341A1 HK 1116341 A1 HK1116341 A1 HK 1116341A1 HK 08106684 A HK08106684 A HK 08106684A HK 1116341 A1 HK1116341 A1 HK 1116341A1
Authority
HK
Hong Kong
Prior art keywords
production
polymeric coating
polymer mixtures
mixed polymeric
pharmaceutical formulation
Prior art date
Application number
HK08106684.0A
Other languages
English (en)
Chinese (zh)
Inventor
．梅爾
．努彭
．彼德雷特
Original Assignee
羅姆有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 羅姆有限公司 filed Critical 羅姆有限公司
Publication of HK1116341A1 publication Critical patent/HK1116341A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
HK08106684.0A 2005-05-25 2008-06-18 Use of polymer mixtures for the production of coated pharmaceutical formulations and pharmaceutical formulation with mixed polymeric coating HK1116341A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005024614A DE102005024614A1 (de) 2005-05-25 2005-05-25 Verwendung von Polymermischungen zur Herstellung von überzogenen Arzneiformen sowie Arzneiform mit polymerem Mischüberzug
PCT/EP2006/001949 WO2006125483A1 (de) 2005-05-25 2006-03-03 Verwendung vom polymermischungen zur herstellung von überzogenen arzneiformen sowie arzneiform mit

Publications (1)

Publication Number Publication Date
HK1116341A1 true HK1116341A1 (en) 2008-12-19

Family

ID=36607494

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08106684.0A HK1116341A1 (en) 2005-05-25 2008-06-18 Use of polymer mixtures for the production of coated pharmaceutical formulations and pharmaceutical formulation with mixed polymeric coating

Country Status (16)

Country Link
US (1) US20080193522A1 (xx)
EP (1) EP1890682B1 (xx)
JP (1) JP5582701B2 (xx)
KR (1) KR101387835B1 (xx)
CN (1) CN101137354B (xx)
BR (1) BRPI0610206B8 (xx)
CA (1) CA2606587C (xx)
DE (1) DE102005024614A1 (xx)
ES (1) ES2628962T3 (xx)
HK (1) HK1116341A1 (xx)
HU (1) HUE032869T2 (xx)
IL (1) IL187535A0 (xx)
MX (1) MX363064B (xx)
PL (1) PL1890682T3 (xx)
SI (1) SI1890682T1 (xx)
WO (1) WO2006125483A1 (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2570916C (en) 2004-06-16 2013-06-11 Tap Pharmaceutical Products, Inc. Pulsed release dosage form of a ppi
US20080292695A1 (en) * 2006-12-01 2008-11-27 Kristin Arnold Carvedilol forms, compositions, and methods of preparation thereof
EP2124552A4 (en) * 2007-01-31 2013-01-09 Methylation Sciences Internat Srl PHARMACEUTICAL FORMULATIONS WITH PROLONGED RELEASE OF S-ADENOSYLMETHIONINE
MX2010003036A (es) * 2007-09-21 2010-04-09 Evonik R Hm Gmbh Composicion farmaceutica de liberacion controlada ph dependiente para no opioides con resistencia a la influencia del etanol.
ES2393934T3 (es) 2007-09-21 2013-01-02 Evonik Röhm Gmbh Composición farmacéutica opioide de lberación controlada dependiente del PH con resitencia frente a la influencia del etanol
RU2010119041A (ru) * 2007-10-12 2011-11-20 Такеда Фармасьютикалз Норт Америка, Инк. (Us) Способы лечения нарушений желудочно-кишечного тракта, независимого от потребления пищи
GEP20135845B (en) 2008-03-11 2013-06-10 Takeda Pharmaceutical Orally-disintegrating solid formulation
CA2729015A1 (en) 2008-06-26 2009-12-30 Mcneil-Ppc, Inc. Coated particles containing pharmaceutically active agents
BRPI0823128B8 (pt) * 2008-09-24 2022-07-05 Evonik Roehm Gmbh composição farmacêutica de liberação controlada dependente do ph para não opioides com resistência contra a influência de etanol, e processo para sua preparação
CN104984343B (zh) * 2008-09-24 2019-04-02 赢创罗姆有限公司 耐受乙醇影响的非阿片类药物的pH依赖性受控释放的药物组合物
CA2738078C (en) * 2008-09-24 2015-12-29 Evonik Roehm Gmbh Ph-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol
WO2010077669A2 (en) * 2008-12-08 2010-07-08 Teva Pharmaceutical Industries Ltd. Palonosetron formulation
KR20120003436A (ko) * 2009-03-18 2012-01-10 에보니크 룀 게엠베하 중합체 혼합물 및 부형제를 포함하는 코팅을 이용하는, 에탄올의 영향에 대한 내성을 갖는 제어 방출 제약 조성물
CN105287434A (zh) * 2009-03-18 2016-02-03 赢创罗姆有限公司 采用含有中性乙烯基聚合物和赋形剂的包衣的具有耐乙醇影响的控释药物组合物
KR101571198B1 (ko) 2009-03-18 2015-11-23 에보니크 룀 게엠베하 중성 비닐 중합체 및 부형제를 포함하는 코팅을 이용하는, 에탄올의 영향에 대한 내성을 갖는 제어 방출 제약 조성물
US20100303920A1 (en) * 2009-05-27 2010-12-02 Johan Hjartstam Aqueous Film Coating Composition / 841
US8329208B2 (en) 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
US20120219626A1 (en) * 2009-10-22 2012-08-30 Niels Jaap Osinga Pharmaceutical Compositions of Sevelamer
MX356579B (es) * 2011-06-17 2018-06-05 Evonik Roehm Gmbh Composicion farmaceutica o nutraceutica de resistencia gastrica con resistencia contra la influenza de etanol.
CA2936748C (en) 2014-10-31 2017-08-08 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
CA2986188A1 (en) 2015-06-05 2016-12-08 Evonik Rohm Gmbh Pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
JP6739275B2 (ja) * 2016-08-02 2020-08-12 日本化薬株式会社 ゲフィチニブを有効成分とする医薬組成物
IT201700032367A1 (it) * 2017-03-23 2018-09-23 Lamberti Spa Dispersioni poliuretaniche acquose
JP2021515778A (ja) * 2018-03-09 2021-06-24 エボニック オペレーションズ ゲーエムベーハー エタノールの影響に対する耐性を有するポリマー混合物
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
US12152166B2 (en) 2019-06-07 2024-11-26 Nippon Soda Co., Ltd. Wet coating agent for fine particles
US20220257517A1 (en) * 2019-06-13 2022-08-18 Evonik Operations Gmbh Powder composition comprising a copolymer mixture and a water-soluble cellulose
CN111700871A (zh) * 2020-06-24 2020-09-25 杭州巴洛特生物科技有限公司 一种美沙拉嗪组合物及其制备方法
CN112237572A (zh) * 2020-10-28 2021-01-19 海南卫康制药(潜山)有限公司 一种富马酸沃诺拉赞片剂及其制备方法
CN114409998A (zh) * 2021-12-24 2022-04-29 浙江普利特新材料有限公司 一种蜂窝状咖啡炭复合隔音降噪聚丙烯材料及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019397A (en) * 1988-04-21 1991-05-28 Alza Corporation Aqueous emulsion for pharmaceutical dosage form
IT1227899B (it) * 1988-12-23 1991-05-14 Poli Ind Chimica Spa Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
DE9414066U1 (de) * 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform
JPH09323926A (ja) * 1996-03-15 1997-12-16 Nikken Chem Co Ltd バルプロ酸ナトリウムの徐放性錠剤
HUP0203623A2 (hu) * 1999-08-31 2003-02-28 Grünenthal GmbH Tramadol-szacharinátot tartalmazó, késleltetett hatású adagolási forma és alkalmazása
DE10013029A1 (de) * 2000-03-17 2001-09-20 Roehm Gmbh Mehrschichtige Arzneiform für die Colonfreigabe
EP1416922A1 (en) * 2001-07-16 2004-05-12 AstraZeneca AB Pharmaceutical formulation comprising a proton pump inhibitor and antacids
HUP0401732A2 (hu) * 2001-10-15 2004-12-28 Röhm GmbH & Co. KG Kopolimerek használata aktív szerként peptidet és fehérjét tartalmazó galenikus formák előállításához
UY28056A1 (es) * 2002-10-31 2003-12-31 Alza Corp Formas de dosificacion que proporcionan la liberacion ascendente de una formulacion liquida.
EP1589951B1 (en) * 2003-01-03 2017-08-09 Supernus Pharmaceuticals, Inc. Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics
MXPA04010956A (es) * 2003-01-30 2005-01-25 Roehm Gmbh Forma de dosis farmaceutica y metodo para la produccion de la misma.
CA2543689A1 (en) * 2003-10-31 2005-05-12 Hexal Ag Pharmaceutical actve-ingredient-containing formulation with coating

Also Published As

Publication number Publication date
JP2008542211A (ja) 2008-11-27
DE102005024614A1 (de) 2006-11-30
KR101387835B1 (ko) 2014-04-25
CA2606587A1 (en) 2006-11-30
EP1890682A1 (de) 2008-02-27
HUE032869T2 (en) 2017-11-28
BRPI0610206A2 (pt) 2010-06-01
MX363064B (es) 2019-03-06
US20080193522A1 (en) 2008-08-14
PL1890682T3 (pl) 2017-10-31
CN101137354B (zh) 2014-06-11
BRPI0610206B1 (pt) 2020-10-06
EP1890682B1 (de) 2017-05-03
WO2006125483A1 (de) 2006-11-30
CN101137354A (zh) 2008-03-05
JP5582701B2 (ja) 2014-09-03
BRPI0610206B8 (pt) 2022-07-05
IL187535A0 (en) 2008-03-20
ES2628962T3 (es) 2017-08-04
SI1890682T1 (sl) 2017-10-30
MX2007014024A (es) 2008-04-09
CA2606587C (en) 2015-05-26
KR20080009213A (ko) 2008-01-25

Similar Documents

Publication Publication Date Title
IL187535A0 (en) Use of polymer mixtures for the production of coated pharmaceutical formulations and pharmaceutical formulation with mixed polymeric coating
IL201176A (en) 4-amino-1-h-pyrazolo [3,4- d] pyrimidine-3-ram-phenyl, a pharmaceutical containing them and their use in the preparation of a drug
IL200695A (en) History of Hydro-Oxazolo [2,3-a] Pyrimidine-7-Wen and Pharmaceutical Preparations Containing Them
IL196033A0 (en) Pyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL245365A0 (en) ATP-linked cassette transport modulators, pharmaceutical preparations containing them and their uses
EP2147957A4 (en) HYDROPHILIC COATING COMPOSITION AND HYDROPHILIC ELEMENT THEREWITH
IL177283A (en) Pyrazolopyrimidine compounds, their use in the preparation of medicines and pharmaceuticals containing them
IL231576A (en) Derivatives of adamantyl-acetamide, the pharmaceutical compositions containing them and their use in the preparation of medicines
IL189187A (en) Polymeric couplings of a252-k and their history, their pharmaceutical preparations and their uses
PL1960482T3 (pl) Stabilna w przechowywaniu kompozycja powłokowa odporna na ścieranie i odporna na zwietrzenie, zapewniająca gładkie powierzchnie nieorganiczne o właściwościach łatwych do czyszczenia
IL183583A0 (en) Quinazoline derivatives and pharmaceutical compositions containing the same
IL189782A (en) The history of sulfonylpyrol and its medicinal products and their use
IL210452A (en) Annotations of dimethyl-oxo-dihydro- (pyridine-3-or-4-ram) -phenyl-6-methyl-6-phenyl- [1,3] -oxiazine-2-one
IL196891A (en) Annals @@@ - Amino - @@@@@@@ - Tetrahydro - H9 - Carbazole - 9 - Yl) - Acetic Acid, Containing Pharmaceuticals
BRPI0814608A2 (pt) Composições de lodo propelente revestido com resina e métodos de produção e uso das mesmas
HK1244819A1 (zh) Foxm1肽和包含foxm1肽的藥劑
IL193164A0 (en) Polymeric conjugates of 7-ethyl-10-hydroxycamptothecin and pharmaceutical compositions containing the same
ZA200608029B (en) Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
IL195861A0 (en) Thienopyrimidine derivatives and pharmaceutical compositions containing the same
IL190522A (en) A medicinal product containing hydrocarbon testosterone gel and use of testosterone to make the preparation
ZA200805027B (en) Use of film-forming hair-care polymers from the group of polyurethanes and pharmaceutical preparations and plasters containing said polymers
IL179296A0 (en) Amphiphilic polymer compositions and their use
IL206125A (en) Derivatives of 7-phenylamino pyrolo [2,1- c] pyrimidine-7-carboxylic acid, esters and their amides, and pharmaceutical preparations containing them
ZA200801006B (en) Polymer coatings containing phytochemical agents and methods for making and using same
GB2442121B (en) Liquid polymeric coating compositions and air bags coated therewith

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230301